Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Insiders of US-listed companies filed 24 open-market purchases worth about $14.7M at 14 companies and 331 open-market sales worth about $177M.
Purchases
24
~$14.7M
Companies bought
14
Sales
331
~$177M
Companies sold
62
Executive Chairman · Sunrise Realty Trust SUNS · bought Jan 29, 2025
~$12M
Chief Executive Officer · Ally Financial ALLY · bought Jan 27, 2025
~$1M
Many sales follow a plan set up months earlier, or cover taxes, and say little. They are listed here for completeness.
Director · Neurocrine Biosciences NBIX · sold Jan 27, 2025
~$21.8M
CMO & EVP Dev & Med Affairs · Alnylam Pharmaceuticals ALNY · sold Jan 27, 2025
~$15M
A day is the US Eastern day an insider’s Form 4 was accepted by the SEC, which is what US markets run on. A filing our nightly update picked up over a weekend is counted on the Friday before. Only open-market purchases and sales are counted; grants, option exercises, tax withholding and gifts are left out. Where a purchase is $50,000 or more and old enough, the chip shows how the stock did against the S&P 500 after it was reported. This lists what was filed and is not investment advice.
10% owner · Atlanta Braves Holdings BATRA · bought Jan 28, 2025
~$722K
10% owner · Atlanta Braves Holdings BATRA · bought Jan 27, 2025
~$214K
Chief Financial Officer · Trisalus Life Sciences TLSI · bought Jan 27, 2025
~$130K
Pres. Research & Development · Processa Pharmaceuticals PCSA · bought Jan 27, 2025
~$99K
Chief Executive Officer · Alset AEI · bought Jan 27, 2025
~$93K
Director · Dentsply Sirona XRAY · bought Nov 18, 2024
~$92K
Chief Manuf, Strategy&Bus Dev. · Trisalus Life Sciences TLSI · bought Jan 27, 2025
~$80K
Chief Manuf, Strategy&Bus Dev. · Trisalus Life Sciences TLSI · bought Jan 28, 2025
~$78K
Chief Executive Officer · Processa Pharmaceuticals PCSA · bought Jan 27, 2025
~$70K
Chief Business - Strategy Off · Processa Pharmaceuticals PCSA · bought Jan 27, 2025
~$35K
CEO AND PRESIDENT · Trisalus Life Sciences TLSI · bought Jan 27, 2025
~$26K
CEO AND PRESIDENT · Trisalus Life Sciences TLSI · bought Jan 28, 2025
~$24K
Director · Dentsply Sirona XRAY · bought Nov 15, 2024
~$18K
Director · Anixa Biosciences ANIX · bought Jan 28, 2025
~$14K
Director · Avita Medical RCEL · bought Dec 9, 2024
~$6.4K
Co-Founder · Mdb Capital Holdings, LLC MDBH · bought Jan 27, 2025
~$5.8K
President and COO · Ovid Therapeutics OVID · bought Jan 27, 2025
~$5K
Chief Medical Officer · Nexalin Technology NXL · bought Jan 28, 2025
~$4K
HORIZON KINETICS ASSET MANAGEMENT LLC
10% owner · Texas Pacific Land Corporation TPL · bought Jan 28, 2025
~$1.3K
CEO · Big Sky Industrial BSIN · bought Jan 28, 2025
~$1.2K
CEO · Big Sky Industrial BSIN · bought Jan 27, 2025
~$1.2K
Co-Founder · Mdb Capital Holdings, LLC MDBH · bought Jan 29, 2025
~$87
EVP & CFO & Enterprise Technol · Intuitive Surgical ISRG · sold Jan 28, 2025
~$3.52M
SEE REMARKS · Samsara IOT · sold Jan 29, 2025
~$3.1M
COB and CEO · Meta META · sold Jan 29, 2025
~$2.49M
EVP, Core Services & Equipment · Schlumberger SLB · sold Jan 29, 2025
~$2.49M
10% owner · Redwire RDW · sold Jan 27, 2025
~$2.27M
COB and CEO · Meta META · sold Jan 28, 2025
~$2.19M
SEE REMARKS · Samsara IOT · sold Jan 28, 2025
~$2.01M
COB and CEO · Meta META · sold Jan 29, 2025
~$1.96M
CO-CHIEF EXECUTIVE OFFICER · Revolve Group RVLV · sold Jan 29, 2025
~$1.84M
CO-CHIEF EXECUTIVE OFFICER · Revolve Group RVLV · sold Jan 29, 2025
~$1.84M
10% owner · Revolve Group RVLV · sold Jan 29, 2025
~$1.84M
COB and CEO · Meta META · sold Jan 29, 2025
~$1.82M
COB and CEO · Meta META · sold Jan 29, 2025
~$1.81M